Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom Decroo

Showing results (111-120 of 138) with videos related to

Pageof 14
Sort By:
Plos One|February 22, 2024
Correction: How to bring residents' psychosocial well-being to the heart of the fight against Covid-19 in Belgian nursing homes-A qualitative studySanne Kaelen, Wilma van den Boogaard, Umberto Pellecchia, et al.
Science (New York, N.Y.)|July 17, 2012
Public health. Getting HIV treatment to the most peopleSharonann Lynch, Nathan Ford, Gilles van Cutsem, et al.
Tropical Medicine & International Health : TM & IH|January 3, 2022
Person-centred care and short oral treatment for rifampicin-resistant tuberculosis improve retention in care in Kandahar, AfghanistanAnita Mesic, Sadiqullah Ishaq, Waliullah H Khan, et al.
International Health|April 14, 2022
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort studyMahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, et al.
The American Journal of Tropical Medicine and Hygiene|July 4, 2020
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant TuberculosisJean Claude Semuto Ngabonziza, Armand Van Deun, Patrick Migambi, et al.
International Journal of Mycobacteriology|September 18, 2023
Rifampicin resistance conferring mutations among <i>Mycobacterium tuberculosis</i> strains in RwandaIsabel Cuella-Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 12, 2025
Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern AfricaAlfred Kipyegon Keter, Alastair Van Heerden, Tom Decroo, et al.
BMC Infectious Diseases|April 6, 2026
Prevalence of nontuberculous mycobacteria isolates and pulmonary disease from respiratory tract samples in persons investigated for presumed tuberculosis from three West African countries, an analysis of three prospective cohort studiesElizabeth Tabitha Abbew, Souleymane Mahamadou Bassirou, Isiyaku Ahmadu, et al.
Plos One|January 19, 2024
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of IraqHiwot Melak Tesfahun, Layth Al-Salihi, Nadia Abdulkareem Al-Ani, et al.
The European Respiratory Journal|May 23, 2024
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, AfghanistanAnita Mesic, Ine Decuyper, Sadiqqullah Ishaq, et al.
Pageof 14

Showing results (111-120 of 138) with videos related to

Sort By:
Pageof 14
Plos One|February 22, 2024
Correction: How to bring residents' psychosocial well-being to the heart of the fight against Covid-19 in Belgian nursing homes-A qualitative studySanne Kaelen, Wilma van den Boogaard, Umberto Pellecchia, et al.
Science (New York, N.Y.)|July 17, 2012
Public health. Getting HIV treatment to the most peopleSharonann Lynch, Nathan Ford, Gilles van Cutsem, et al.
Tropical Medicine & International Health : TM & IH|January 3, 2022
Person-centred care and short oral treatment for rifampicin-resistant tuberculosis improve retention in care in Kandahar, AfghanistanAnita Mesic, Sadiqullah Ishaq, Waliullah H Khan, et al.
International Health|April 14, 2022
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort studyMahamadou Bassirou Souleymane, Tom Decroo, Saïdou Mamadou, et al.
The American Journal of Tropical Medicine and Hygiene|July 4, 2020
Case Report: Dynamics of Acquired Fluoroquinolone Resistance under Standardized Short-Course Treatment of Multidrug-Resistant TuberculosisJean Claude Semuto Ngabonziza, Armand Van Deun, Patrick Migambi, et al.
International Journal of Mycobacteriology|September 18, 2023
Rifampicin resistance conferring mutations among <i>Mycobacterium tuberculosis</i> strains in RwandaIsabel Cuella-Martin, Jean Claude Semuto Ngabonziza, Gabriela Torrea, et al.
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases|May 12, 2025
Estimation of therapeutic threshold for tuberculosis using adapted nominal group technique and clinical vignettes in clinical and community settings in Southern AfricaAlfred Kipyegon Keter, Alastair Van Heerden, Tom Decroo, et al.
BMC Infectious Diseases|April 6, 2026
Prevalence of nontuberculous mycobacteria isolates and pulmonary disease from respiratory tract samples in persons investigated for presumed tuberculosis from three West African countries, an analysis of three prospective cohort studiesElizabeth Tabitha Abbew, Souleymane Mahamadou Bassirou, Isiyaku Ahmadu, et al.
Plos One|January 19, 2024
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of IraqHiwot Melak Tesfahun, Layth Al-Salihi, Nadia Abdulkareem Al-Ani, et al.
The European Respiratory Journal|May 23, 2024
Short oral treatment regimens for rifampicin-resistant tuberculosis are safe and effective for young children: results from a field-based, non-randomised clinical trial from Kandahar, AfghanistanAnita Mesic, Ine Decuyper, Sadiqqullah Ishaq, et al.
Pageof 14